Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC.

Lin HC, Zhang FL, Geng Q, Yu T, Cui YQ, Liu XH, Li J, Yan MX, Liu L, He XH, Li JJ, Yao M.

J Proteome Res. 2013 Jul 5;12(7):3423-33. doi: 10.1021/pr400273z. Epub 2013 Jun 6.

PMID:
23713811
2.

The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.

Chen WL, Kuo KT, Chou TY, Chen CL, Wang CH, Wei YH, Wang LS.

BMC Cancer. 2012 Jun 29;12:273. doi: 10.1186/1471-2407-12-273.

3.

SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.

Zhang F, Lin H, Gu A, Li J, Liu L, Yu T, Cui Y, Deng W, Yan M, Li J, Yao M.

J Proteomics. 2014 May 6;102:125-36. doi: 10.1016/j.jprot.2014.03.007. Epub 2014 Mar 22.

PMID:
24667143
4.

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.

Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E.

BMC Cancer. 2010 Jun 22;10:318. doi: 10.1186/1471-2407-10-318.

5.

Quantitative proteomic analysis of the metastasis-inhibitory mechanism of miR-193a-3p in non-small cell lung cancer.

Deng W, Yan M, Yu T, Ge H, Lin H, Li J, Liu Y, Geng Q, Zhu M, Liu L, He X, Yao M.

Cell Physiol Biochem. 2015;35(5):1677-88. doi: 10.1159/000373981. Epub 2015 Mar 18.

6.

MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b.

Li Y, Chao Y, Fang Y, Wang J, Wang M, Zhang H, Ying M, Zhu X, Wang H.

J Exp Clin Cancer Res. 2013 May 29;32:33. doi: 10.1186/1756-9966-32-33.

7.

Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells.

Shih JY, Yang SC, Hong TM, Yuan A, Chen JJ, Yu CJ, Chang YL, Lee YC, Peck K, Wu CW, Yang PC.

J Natl Cancer Inst. 2001 Sep 19;93(18):1392-400.

PMID:
11562390
8.

Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.

Su L, Zhang J, Xu H, Wang Y, Chu Y, Liu R, Xiong S.

Clin Cancer Res. 2005 Dec 1;11(23):8273-80.

9.

L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.

Hai J, Zhu CQ, Bandarchi B, Wang YH, Navab R, Shepherd FA, Jurisica I, Tsao MS.

Clin Cancer Res. 2012 Apr 1;18(7):1914-24. doi: 10.1158/1078-0432.CCR-11-2893. Epub 2012 Feb 3.

10.

Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion.

Jia D, Yan M, Wang X, Hao X, Liang L, Liu L, Kong H, He X, Li J, Yao M.

BMC Cancer. 2010 Jul 9;10:364. doi: 10.1186/1471-2407-10-364.

11.

Loss of Med1/TRAP220 promotes the invasion and metastasis of human non-small-cell lung cancer cells by modulating the expression of metastasis-related genes.

Kim HJ, Roh MS, Son CH, Kim AJ, Jee HJ, Song N, Kim M, Seo SY, Yoo YH, Yun J.

Cancer Lett. 2012 Aug 28;321(2):195-202. doi: 10.1016/j.canlet.2012.02.009. Epub 2012 Feb 14.

PMID:
22342682
12.

Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2.

Tang JZ, Kong XJ, Kang J, Fielder GC, Steiner M, Perry JK, Wu ZS, Yin Z, Zhu T, Liu DX, Lobie PE.

Mol Cancer Ther. 2010 Jun;9(6):1697-708. doi: 10.1158/1535-7163.MCT-09-1077. Epub 2010 Jun 8.

13.

Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.

Hu R, Huffman KE, Chu M, Zhang Y, Minna JD, Yu Y.

J Proteome Res. 2016 Feb 5;15(2):477-86. doi: 10.1021/acs.jproteome.5b00819. Epub 2016 Jan 25.

14.

CCR1 knockdown suppresses human non-small cell lung cancer cell invasion.

Wang CL, Sun BS, Tang Y, Zhuang HQ, Cao WZ.

J Cancer Res Clin Oncol. 2009 May;135(5):695-701. doi: 10.1007/s00432-008-0505-0. Epub 2008 Oct 30.

PMID:
18972130
15.

Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach.

Wang LN, Tong SW, Hu HD, Ye F, Li SL, Ren H, Zhang DZ, Xiang R, Yang YX.

J Cell Biochem. 2012 Dec;113(12):3762-72. doi: 10.1002/jcb.24250.

PMID:
22807371
16.

Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling.

Chiu KH, Chang YH, Wu YS, Lee SH, Liao PC.

J Proteome Res. 2011 Mar 4;10(3):1110-25. doi: 10.1021/pr1008724. Epub 2011 Feb 14.

PMID:
21186846
17.

Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.

Terp MG, Lund RR, Jensen ON, Leth-Larsen R, Ditzel HJ.

Cancer Genomics Proteomics. 2012 Sep-Oct;9(5):265-73.

PMID:
22990106
18.

PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186.

Li H, Yin C, Zhang B, Sun Y, Shi L, Liu N, Liang S, Lu S, Liu Y, Zhang J, Li F, Li W, Liu F, Sun L, Qi Y.

Carcinogenesis. 2013 Sep;34(9):2145-55. doi: 10.1093/carcin/bgt158. Epub 2013 May 13.

PMID:
23671127
19.

Quantitative proteomic approach to understand metabolic adaptation in non-small cell lung cancer.

Martín-Bernabé A, Cortés R, Lehmann SG, Seve M, Cascante M, Bourgoin-Voillard S.

J Proteome Res. 2014 Nov 7;13(11):4695-704. doi: 10.1021/pr500327v. Epub 2014 Aug 25.

PMID:
25029028
20.

Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer.

Yang X, Zhang Z, Qiu M, Hu J, Fan X, Wang J, Xu L, Yin R.

Cancer Lett. 2013 Dec 1;341(2):265-73. doi: 10.1016/j.canlet.2013.08.020. Epub 2013 Aug 17.

PMID:
23962560

Supplemental Content

Support Center